Trials / Conditions / Cognitive Symptoms

Cognitive Symptoms

14 registered clinical trials studyying Cognitive Symptoms — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Cognitive Enhancement in Recurrent Depression (The COG-D-R Study) NCT07527273	Vanderbilt University Medical Center	N/A
Recruiting	Cranberry Polyphenols and Stress Resilience During Multitasking in Healthy Adults NCT07453537	University of Florida	N/A
Not Yet Recruiting	PQQ for Cognitive and Negative Symptoms NCT07393464	Tianjin Anding Hospital	N/A
Recruiting	Cognitive Rehabilitation for Refugees With Traumatic Brain Injury and Cognitive Impairment NCT06839079	Massachusetts General Hospital	N/A
Completed	Breast Cancer Patients' Cognitive Symptoms After Information About Chemotherapy-Related Cognitive Symptoms NCT04813965	Radboud University Medical Center	N/A
Completed	Chemotherapy-Induced Cognitive Impairment NCT01578083	Jay F. Piccirillo, MD	—
Terminated	COMO: Cognition Study With HIV+ Patients (CTNPT 015) NCT02144688	Marie-Josée Brouillette	EARLY_Phase 1
Completed	Cognitive Rehabilitation of Blast Traumatic Brain Injury (TBI) NCT01138020	VA Office of Research and Development	N/A
Unknown	Study of Cognitive Inhibition Disorders in Depressed Older Suicide Attempters NCT01333215	University Hospital, Angers	—
Completed	Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment NCT00387062	Posit Science Corporation	Phase 1
Completed	Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS) NCT00391378	National Institute of Neurological Disorders and Stroke (NINDS)	—
Unknown	Cognitive Remediation in Supported Employment at Human Service Center (HSC) NCT00138021	Human Service Center, Illinois	N/A
Completed	Oral Vitamin B12 Supplementation and Cognitive Performance in Elderly People NCT00111267	Wageningen University	N/A
Terminated	Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment NCT00134953	Novartis	Phase 3